Episodebeskrivelse
In this episode of "In the Interim…", Dr. Scott Berry and Dr. Kert Viele, Director of Research at Berry Consultants, review the European Medicines Agency's draft reflection paper on methodological aspects in confirmatory platform trials. They walk through the paper's definition of a platform trial and explain why the shared control arm is the source of both the efficiency and the complexity of these designs. Scott and Kert discuss the paper's preference for constant allocation ratios between each arm and control, its position that response adaptive randomization is not supported, two-stage…
Website: share.transistor.fm

